# Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.

> **NCT05272878** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 508 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** IRBESARTAN, tablet, 150 mg
- **DRUG:** Placebo, tablet, 150 mg

## Key facts

- **NCT ID:** NCT05272878
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-22
- **Primary completion:** 2025-06-27
- **Final completion:** 2026-06-27
- **Target enrollment:** 508 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05272878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05272878, "Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05272878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*